Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia Correspondence: Professor M Scherr or Professor M Eder, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg Strasse 1, Hannover 30623, Germany.
http://www.nature.com/leu/journal/vaop/ncurrent/full/leu2013361a.html
http://www.nature.com/leu/journal/vaop/ncurrent/full/leu2013361a.html
No comments:
Post a Comment